Non-invasive Neuromodulation of the Brain, Treatment Options to Manage Locomotion Deficits, Migraine, and Clinical Depression

Episodic, and chronic migraines as well as tension headaches are multifaceted clinical diagnoses affecting at least 12% of the population worldwide from adolescence to advanced age. Several medically recognized co-morbidities include vestibular migraine, vascular migraine, significant association with neuro-psychiatric disorders notably major depression, and post traumatic concussion. Both headaches and depression are reported by patients with brain damage including post-stroke, and Parkinson’s disease. Dysregulated excitation thresholds affecting various neural networks within the brain are implicated in these medical diagnoses. Numerous evidence-based, multicenter, placebo-controlled studies, are published in peer-reviewed journals where biomedical researchers, rehabilitation clinicians, neurologists, and psychiatrists have used direct current (DC) also known as tDCS, and pulsed current (PC) also known as tPCS to manage signs and symptoms associated with damage to the brain and/or cranial nerves specifically the Trigeminal, Vagus, and Occipital nerves. Over the past 10-15 years these studies report much better clinical outcomes in several areas of medical practice. This session will review the electrophysiological science and the latest advancement in electrotherapeutic technology and offer new intervention options to complement the behavioral interventions provided by clinicians. Beneficiaries are patients coping with migraines, major depression, and those with impaired locomotion ability following stroke or Parkinson’s disease.
 

Presenter

Gad Alon

 

Dr. Gad Alon, PT, Ph.D.

GAlon@som.umaryland.edu

https://www.medschool.umaryland.edu/profiles/Alon-Gad/

Dr. Alon is an Emeritus Associate Professor in the school of Medicine, Department of Physical Therapy and Rehabilitation Science. He was a core faculty until retiring in 2012.  The core of his research endeavor has been to develop, test and help bring to the market new treatment options to treat slow-to-heal wounds, to manage acute inflammation, to strengthen weak-sarcopenic skeletal muscles, and assist in the recovery following damage the central nervous system (CNS) using both functional electrical stimulation (FES) and neuromodulation in the form of non-invasive electrical stimulation of the brain (ESB). In recent years, Dr. Alon began focusing on the design, development, testing and deployment of wearable wireless self-administered FES and EBS systems with the goal of making FES and EBS a standard-of-care option in the discipline of rehabilitation medicine world-wide. Prior to retirement, his major teaching included electrotherapy, management of limb amputation, management of pathological movements and therapeutic technologies. He has been awarded faculty of the year 6 times and his research and teaching has earned him world recognition in the field of clinical electrotherapy. Dr. Alon is invited frequently to share his interest and knowledge with clinicians and scientists Throughout the USA and around the world. He was a member of the board of directors of IFESS from 2014 to 2018. He is an adjunct Associate Professor in the Rehabilitation Science department at George Mason University.


Moderator

Dr. Tamsyn Street, Salisbury NHS foundation Trust, UK

 
Event Fee
IFESS members € 0.00
Non-IFESS members (approx. £ 5.64 and $ 7.85) € 6.50

Download iCalendar entry for this event. iCalendar feed for this event.